- Home
- CCM vs ALLR Comparison
CCM vs ALLR Comparison
Compare CCM & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- ALLR
- Stock Information
- Founded
- CCM 1997
- ALLR 2004
- Country
- CCM China
- ALLR United States
- Employees
- CCM N/A
- ALLR N/A
- Industry
- CCM Medical/Nursing Services
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- CCM Health Care
- ALLR Health Care
- Exchange
- CCM Nasdaq
- ALLR Nasdaq
- Market Cap
- CCM 25.6M
- ALLR 21.8M
- IPO Year
- CCM 2009
- ALLR N/A
- Fundamental
- Price
- CCM $5.70
- ALLR $1.44
- Analyst Decision
- CCM
- ALLR Strong Buy
- Analyst Count
- CCM 0
- ALLR 1
- Target Price
- CCM N/A
- ALLR $9.25
- AVG Volume (30 Days)
- CCM 26.0K
- ALLR 479.4K
- Earning Date
- CCM 09-26-2025
- ALLR 11-13-2025
- Dividend Yield
- CCM N/A
- ALLR N/A
- EPS Growth
- CCM N/A
- ALLR N/A
- EPS
- CCM N/A
- ALLR N/A
- Revenue
- CCM $51,056,841.00
- ALLR N/A
- Revenue This Year
- CCM N/A
- ALLR N/A
- Revenue Next Year
- CCM N/A
- ALLR N/A
- P/E Ratio
- CCM N/A
- ALLR N/A
- Revenue Growth
- CCM N/A
- ALLR N/A
- 52 Week Low
- CCM $3.80
- ALLR $0.61
- 52 Week High
- CCM $10.77
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- CCM 47.73
- ALLR 42.92
- Support Level
- CCM $5.62
- ALLR $1.45
- Resistance Level
- CCM $6.96
- ALLR $1.80
- Average True Range (ATR)
- CCM 0.49
- ALLR 0.12
- MACD
- CCM 0.00
- ALLR -0.03
- Stochastic Oscillator
- CCM 22.25
- ALLR 10.00
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company is involved in the leasing of radiotherapy and diagnostic imaging equipment, provision of management services to hospitals, medicine sales, and provision of premium cancer and proton treatment services. The company has two operating segments, including network and hospital. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.